Table 2.
Demographic information of the participating clinicians who completed all three rounds of the Delphi survey (n = 116)
| Characteristic | Value |
|---|---|
| Age (years) | |
| <31 | 3 (2.6) |
| 31–50 | 66 (56.9) |
| 51–70 | 47 (40.5) |
| Sex | |
| Male | 84 (72.4) |
| Female | 32 (27.6) |
| Profession | |
| Surgeon | 91 (78.4) |
| Nurse | 7 (6.0) |
| Radiation oncologist | 4 (3.4) |
| Anaesthetist | 4 (3.4) |
| Medical oncologist | 3 (2.6) |
| Dietitian | 3 (2.6) |
| Radiologist | 2 (1.7) |
| Nuclear medicine specialist | 1 (0.8) |
| Administrator | 1 (0.8) |
| Region | |
| Europe and Central Asia | 57 (49.1) |
| Australasia and Pacific | 31 (26.7) |
| North America | 20 (17.2) |
| East Asia | 3 (2.6) |
| Latin America | 3 (2.6) |
| South Asia | 2 (1.7) |
| Dedicated exenteration training (surgeons only) | |
| Yes | 58 (50.0) |
| No | 28 (24.1) |
| Not applicable | 30 (25.9) |
| Experience treating advanced and recurrent rectal cancer (years) | |
| <5 | 29 (25.0) |
| 5–10 | 29 (25.0) |
| 11–20 | 38 (32.8) |
| >20 | 20 (17.2) |
| Access to dedicated pelvic oncology MDT meeting | |
| Yes | 106 (91.4) |
| No | 10 (8.6) |
| Annual centre pelvic exenteration case volume, median (interquartile range) | 30 (18–50) |
Values are n (%) unless otherwise indicated. MDT, multidisciplinary team.